1,012
Views
9
CrossRef citations to date
0
Altmetric
Short Communication

Inhibition of human pyridoxal kinase by 2-acetyl-4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)imidazole (THI)

, , &
Pages 336-340 | Received 28 Feb 2014, Accepted 02 Apr 2014, Published online: 05 Jun 2014

References

  • Joint FAO/WHO Expert Committee on Food Additives. Caramel colours (ammonia process). Toxicological evaluation of some enzymes, modified starches, and certain other substances 1972. No. 240
  • Elsinghorst PW, Raters M, Dingel A, et al. Synthesis and application of 13C-labeled 2-acetyl-4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)imidazole (THI), an immunosuppressant observed in caramel food colorings. J Agric Food Chem 2013;61:7494–9
  • Aguilar F, Dusemund B, Galtier P, et al. Scientific opinion on the re-evaluation of caramel colours (E 150 a,b,c,d) as food additives. EFSA J 2011;9:2004
  • Kamuf W, Nixon A, Parker O, Barnum GC. Overview of caramel colors. Cereal Foods World 2003;48:64–9
  • Sengar G, Sharma HK. Food caramels: a review. J Food Sci Technol 2012;49:1–11
  • Gaunt IF, Lloyd AG, Grasso P, et al. Short-term study in the rat on two caramels produced by variations of the “Ammonia process”. Food Cosmet Toxicol 1977;15:509–21
  • Joint FAO/WHO Expert Committee on Food Additives. Caramel colours. Thirteenth report. Geneva: WHO; 1970:10–12
  • Evans JG, Butterworth KR, Gaunt IF, Grasso P. Long-term toxicity study in the rat on a caramel produced by the “half open-half closed pan” ammonia process. Food Cosmet Toxicol 1977;15:523–31
  • Kröplien U, Rosdorfer J, van der Greef J, et al. 2-Acetyl-4(5)-(1,2,3,4-tetrahydroxybutyl)imidazole: detection in commercial caramel color III and preparation by a model browning reaction. J Org Chem 1985;50:1131–3
  • Sinkeldam EJ, de Groot AP, van den Berg H, Chappel CI. The effect of pyridoxine on the number of lymphocytes in the blood of rats fed caramel colour (III). Food Chem Toxicol 1988;26:195–203
  • Spector R, Huntoon S. Effects of caramel color (ammonia process) on mammalian vitamin B6 metabolism. Toxicol Appl Pharmacol 1982;62:172–8
  • Kästner U, Hallmen C, Wiese M, et al. The human pyridoxal kinase, a plausible target for ginkgotoxin from Ginkgo biloba. FEBS J 2007;274:1036–45
  • Ubbink JB, Bissbort S, Vermaak WJ, Delport R. Inhibition of pyridoxal kinase by methylxanthines. Enzyme 1990;43:72–9
  • Gandhi AK, Desai JV, Ghatge MS, et al. Crystal structures of human pyridoxal kinase in complex with the neurotoxins, ginkgotoxin and theophylline: insights into pyridoxal kinase inhibition. PLoS One 2012;7:e40954
  • Lainé-Cessac P, Cailleux A, Allain P. Mechanisms of the inhibition of human erythrocyte pyridoxal kinase by drugs. Biochem Pharmacol 1997;54:863–70
  • Houben GF, van den Berg H, Kuijpers MH, et al. Effects of the color additive caramel color III and 2-acetyl-4(5)-tetrahydroxybutylimidazole (THI) on the immune system of rats. Toxicol Appl Pharmacol 1992;113:43–54
  • Bagdanoff JT, Donoviel MS, Nouraldeen A, et al. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders. J Med Chem 2009;52:3941–53
  • Musayev FN, di Salvo ML, Ko T-P, et al. Crystal structure of human pyridoxal kinase: structural basis of M+ and M2+ activation. Protein Sci 2007;16:2184–94
  • Metzler DE, Snell EE. Spectra and ionization constants of the vitamin B6 group and related 3-hydroxypyridine derivatives. J Am Chem Soc 1955;77:2431–7
  • Nakamoto K, Martell AE. Pyridoxine and pyridoxal analogs. IV. Ultraviolet spectra and solution equilibria of 3-methoxypyridine-2(and 4-)-aldehydes and of 3-hydroxypyridine-2(and 4-)-aldehydes. J Am Chem Soc 1959;81:5863–9
  • Di Salvo ML, Hunt S, Schirch V. Expression, purification, and kinetic constants for human and Escherichia coli pyridoxal kinases. Protein Expr Purif 2004;36:300–6
  • Bisswanger H. Enzyme kinetics: principles and methods. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2008
  • Di Salvo ML, Safo MK, Contestabile R. Biomedical aspects of pyridoxal 5′-phosphate availability. Front Biosci 2012;4:897–913
  • Di Salvo ML, Contestabile R, Safo MK. Vitamin B6 salvage enzymes: mechanism, structure and regulation. Biochim Biophys Acta 2011;1814:1597–608
  • Lainé-Cessac P, Allain P. Kinetic studies of the effects of K+, Na+ and Li+ on the catalytic activity of human erythrocyte pyridoxal kinase. Enzyme Protein 1996;49:291–304
  • Beis I, Newsholme EA. The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem J 1975;152:23–32
  • Fu T-F, di Salvo ML, Schirch V. Distribution of B6 vitamers in Escherichia coli as determined by enzymatic assay. Anal Biochem 2001;298:314–21
  • Churchich JE, Wu C. Brain pyridoxal kinase. Mechanism of substrate addition, binding of ATP, and rotational mobility of the inhibitor pyridoxaloxime. J Biol Chem 1981;256:780–4
  • Gandhi AK, Ghatge MS, Musayev FN, et al. Kinetic and structural studies of the role of the active site residue Asp235 of human pyridoxal kinase. Biochem Biophys Res Commun 2009;381:12–15
  • Safo MK, Musayev FN, di Salvo ML, et al. Crystal structure of pyridoxal kinase from the Escherichia coli pdxK gene: implications for the classification of pyridoxal kinases. J Bacteriol 2006;188:4542–52
  • Safo MK, Musayev FN, Hunt S, et al. Crystal structure of the PdxY Protein from Escherichia coli. J Bacteriol 2004;186:8074–82
  • Li M-H, Kwok F, Chang W-R, et al. Crystal structure of brain pyridoxal kinase, a novel member of the ribokinase superfamily. J Biol Chem 2002;277:46385–90
  • Fromm HJ. Initial rate enzyme kinetics. London: Springer; 2012
  • Asante-Appiah E, Chan WW. Analysis of the interactions between an enzyme and multiple inhibitors using combination plots. Biochem J 1996;320:17–26

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.